Results 201 to 210 of about 81,713 (355)

A new era in myeloma: the advent of chimeric antigen receptor‐T (CAR‐T) cells and bispecific antibodies

open access: yesInternal Medicine Journal, EarlyView.
Abstract T‐cell re‐directional therapies, including chimeric antigen receptor (CAR)‐T cell and bispecific antibodies (BsA), have transformed the treatment landscape to benefit patients with multiple myeloma. A number of these novel therapies has been approved internationally, with CAR‐T therapy recently approved in Australia.
P. Joy Ho, Eric W. Li
wiley   +1 more source

Non-Hogkins lymphoma ′masquerading′ as pott′s disease in a 13-year old boy: A case report

open access: yesSahel Medical Journal, 2010
Lymphomas are malignant neoplasms of the lymphoid lineage which are broadly classified as either Hodgkin disease or as non-Hodgkin lymphoma (NHL).
O A Adegboye
doaj  

New approaches to the management of adult acute lymphoblastic leukemia [PDF]

open access: yes
Traditional treatment regimens for adult acute lymphoblastic leukemia, including allogeneic hematopoietic cell transplantation, result in an overall survival of about 40%, a figure hardly comparable with the extraordinary 80-90% cure rate currently ...
Bassan, R   +3 more
core  

Cancer and Accelerated Aging Research at the National Institutes of Health, 2013–2023: A Grant Portfolio Analysis

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT Background The purpose of this study was to describe the characteristics of the NIH‐funded grant portfolio focused on cancer and accelerated aging. Methods Research project grants focused on cancer survivors and aging trajectories that were newly funded during fiscal years 2013 through 2023 were identified by first using a text mining ...
Lisa Gallicchio   +5 more
wiley   +1 more source

Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL [PDF]

open access: bronze, 2003
Takeshi Tsuchiya   +9 more
openalex   +1 more source

Constitutional Mismatch Repair Deficiency: Scoping Review of a Cancer‐Predisposition Syndrome With Distinctive Cutaneous Findings

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Constitutional mismatch repair deficiency (CMMRD) is a rare but severe hereditary cancer predisposition syndrome caused by biallelic pathogenic variants in one of the mismatch repair genes (MLH1, MSH2, MSH6, or PMS2). The condition mainly presents in childhood, with cancers primarily affecting the hematological, brain, and gastrointestinal ...
Kristie Mar, Kimia Ameri, Joseph M. Lam
wiley   +1 more source

Lymphoblastic lymphoma of childhood and the LSA2‐L2 protocol [PDF]

open access: bronze, 2003
Jaume Mora   +3 more
openalex   +1 more source

Prophylactic Vancomycin in the Primary Prevention of Clostridium difficile in Allogeneic Stem Cell Transplant

open access: yesTransplant Infectious Disease, EarlyView.
Prophylactic oral vancomycin was associated with reduced Clostridium difficile infection in allogeneic stem cell transplant patients. No differences in hospital‐acquired infections, mortality, GVHD, or rehospitalization were observed. It is a low‐cost, effective preventative strategy, though further prospective studies are needed to confirm safety and ...
Brendon Fusco   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy